Stocks in play: Stantec

Announced today that it has received approval from the Toronto Stock Exchange respecting the renewal of its Normal Course Issuer Bid. Pursuant to the NCIB documentation filed with the TSX, Stantec may purchase up to 5,538,309 common shares, representing approximately 5% of Stantec’s 110,766,187 issued and outstanding common shares as of November 2, 2022. The purchases may commence on November 16, 2022 and will terminate no later than November 15, 2023. StantecT.STN shares T.STN are trading up $1.87 at $67.59.

Read:

• New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates

• Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America

• Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You

• Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options

• Vegetarian and Vegan Fliers Winning Important Battle Over In-Flight Menu Options